[Effects of a coronary vessel dilating drug (flavone-7-hydroxyethylacetate) on the abnormal phase of repolarization in Wolff-Parkinson-White syndrome].
D003331:Coronary Vessels; D004562:Electrocardiography; D047309:Flavones; D006321:Heart; D006327:Heart Block / Q000628:therapy*; D006801:Humans; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014927:Wolff-Parkinson-White Syndrome
D047309:Flavones; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
ELECTROCARDIOGRAPHY; HEART BLOCK/therapy; VASOMOTOR DRUGS/therapeutic use
Effetti di un farmaco coronarodilatatore (flavon-7-ossiacetato di etile) su le anomalle della fase di ripolarizzazione nella sindrome di Wolff-Parkinson-White.